VITALHUB CORP (VHI.CA) Stock Fundamental Analysis
Canada - Toronto Stock Exchange - TSX:VHI - CA92847V5018 - Common Stock
8.45 CAD
-0.2 (-2.31%)
VHI gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 9 industry peers in the Health Care Technology industry. VHI scores excellent points on both the profitability and health parts. This is a solid base for a good stock. VHI is not priced too expensively while it is growing strongly. Keep and eye on this one! With these ratings, VHI could be worth investigating further for growth and quality investing!.
1. Profitability
1.1 Basic Checks
- In the past year VHI was profitable.
- In the past year VHI had a positive cash flow from operations.
- In multiple years VHI reported negative net income over the last 5 years.
- Of the past 5 years VHI 4 years had a positive operating cash flow.
1.2 Ratios
- VHI has a better Return On Assets (0.76%) than 88.89% of its industry peers.
- VHI's Return On Equity of 1.08% is amongst the best of the industry. VHI outperforms 88.89% of its industry peers.
- VHI has a Return On Invested Capital of 2.86%. This is amongst the best in the industry. VHI outperforms 100.00% of its industry peers.
- VHI had an Average Return On Invested Capital over the past 3 years of 3.96%. This is in line with the industry average of 2.16%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.76% | ||
| ROE | 1.08% | ||
| ROIC | 2.86% |
ROA(3y)2.14%
ROA(5y)0.07%
ROE(3y)3.08%
ROE(5y)0.28%
ROIC(3y)3.96%
ROIC(5y)N/A
1.3 Margins
- VHI has a Profit Margin of 2.88%. This is amongst the best in the industry. VHI outperforms 100.00% of its industry peers.
- VHI's Operating Margin of 12.47% is amongst the best of the industry. VHI outperforms 100.00% of its industry peers.
- In the last couple of years the Operating Margin of VHI has grown nicely.
- VHI has a better Gross Margin (80.92%) than 88.89% of its industry peers.
- In the last couple of years the Gross Margin of VHI has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.47% | ||
| PM (TTM) | 2.88% | ||
| GM | 80.92% |
OM growth 3Y125.53%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.9%
GM growth 5Y2.08%
2. Health
2.1 Basic Checks
- VHI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- VHI has more shares outstanding than it did 1 year ago.
- Compared to 5 years ago, VHI has more shares outstanding
- Compared to 1 year ago, VHI has an improved debt to assets ratio.
2.2 Solvency
- VHI has an Altman-Z score of 3.60. This indicates that VHI is financially healthy and has little risk of bankruptcy at the moment.
- With a Altman-Z score value of 3.60, VHI perfoms like the industry average, outperforming 55.56% of the companies in the same industry.
- The Debt to FCF ratio of VHI is 0.13, which is an excellent value as it means it would take VHI, only 0.13 years of fcf income to pay off all of its debts.
- VHI's Debt to FCF ratio of 0.13 is amongst the best of the industry. VHI outperforms 100.00% of its industry peers.
- VHI has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
- VHI's Debt to Equity ratio of 0.00 is amongst the best of the industry. VHI outperforms 88.89% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.13 | ||
| Altman-Z | 3.6 |
ROIC/WACC0.33
WACC8.66%
2.3 Liquidity
- A Current Ratio of 1.94 indicates that VHI should not have too much problems paying its short term obligations.
- VHI has a better Current ratio (1.94) than 77.78% of its industry peers.
- A Quick Ratio of 1.94 indicates that VHI should not have too much problems paying its short term obligations.
- Looking at the Quick ratio, with a value of 1.94, VHI is in the better half of the industry, outperforming 77.78% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.94 | ||
| Quick Ratio | 1.94 |
3. Growth
3.1 Past
- VHI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -14.29%.
- The Revenue has grown by 59.34% in the past year. This is a very strong growth!
- VHI shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 46.32% yearly.
EPS 1Y (TTM)-14.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-133.33%
Revenue 1Y (TTM)59.34%
Revenue growth 3Y40.63%
Revenue growth 5Y46.32%
Sales Q2Q%94.1%
3.2 Future
- Based on estimates for the next years, VHI will show a very strong growth in Earnings Per Share. The EPS will grow by 70.74% on average per year.
- The Revenue is expected to grow by 27.33% on average over the next years. This is a very strong growth
EPS Next Y-6.21%
EPS Next 2Y86.09%
EPS Next 3Y70.74%
EPS Next 5YN/A
Revenue Next Year60.05%
Revenue Next 2Y38.57%
Revenue Next 3Y27.33%
Revenue Next 5YN/A
3.3 Evolution
- The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 140.83, the valuation of VHI can be described as expensive.
- Based on the Price/Earnings ratio, VHI is valued cheaper than 100.00% of the companies in the same industry.
- VHI's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.38.
- VHI is valuated quite expensively with a Price/Forward Earnings ratio of 34.86.
- Based on the Price/Forward Earnings ratio, VHI is valued cheaper than 88.89% of the companies in the same industry.
- VHI is valuated rather expensively when we compare the Price/Forward Earnings ratio to 24.29, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 140.83 | ||
| Fwd PE | 34.86 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of VHI indicates a rather cheap valuation: VHI is cheaper than 100.00% of the companies listed in the same industry.
- Based on the Price/Free Cash Flow ratio, VHI is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 43.78 | ||
| EV/EBITDA | 18.84 |
4.3 Compensation for Growth
- The decent profitability rating of VHI may justify a higher PE ratio.
- A more expensive valuation may be justified as VHI's earnings are expected to grow with 70.74% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y86.09%
EPS Next 3Y70.74%
5. Dividend
5.1 Amount
- VHI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
TSX:VHI (1/16/2026, 7:00:00 PM)
8.45
-0.2 (-2.31%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-06 2025-11-06/amc
Earnings (Next)03-16 2026-03-16
Inst Owners40.16%
Inst Owner ChangeN/A
Ins Owners11.45%
Ins Owner ChangeN/A
Market Cap533.36M
Revenue(TTM)98.17M
Net Income(TTM)2.83M
Analysts81.33
Price Target15.51 (83.55%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-78.71%
Min EPS beat(2)-129.12%
Max EPS beat(2)-28.31%
EPS beat(4)0
Avg EPS beat(4)-61.43%
Min EPS beat(4)-129.12%
Max EPS beat(4)-28.31%
EPS beat(8)0
Avg EPS beat(8)-58.34%
EPS beat(12)1
Avg EPS beat(12)-46.79%
EPS beat(16)2
Avg EPS beat(16)-54.73%
Revenue beat(2)2
Avg Revenue beat(2)9.95%
Min Revenue beat(2)7.24%
Max Revenue beat(2)12.66%
Revenue beat(4)4
Avg Revenue beat(4)6.3%
Min Revenue beat(4)0.61%
Max Revenue beat(4)12.66%
Revenue beat(8)6
Avg Revenue beat(8)4.15%
Revenue beat(12)10
Avg Revenue beat(12)4.05%
Revenue beat(16)12
Avg Revenue beat(16)4.16%
PT rev (1m)0%
PT rev (3m)-1.75%
EPS NQ rev (1m)-25%
EPS NQ rev (3m)-41.67%
EPS NY rev (1m)-4.1%
EPS NY rev (3m)-44.09%
Revenue NQ rev (1m)0.57%
Revenue NQ rev (3m)4.7%
Revenue NY rev (1m)0.42%
Revenue NY rev (3m)4.24%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 140.83 | ||
| Fwd PE | 34.86 | ||
| P/S | 5.43 | ||
| P/FCF | 43.78 | ||
| P/OCF | 41.29 | ||
| P/B | 2.04 | ||
| P/tB | 10.83 | ||
| EV/EBITDA | 18.84 |
EPS(TTM)0.06
EY0.71%
EPS(NY)0.24
Fwd EY2.87%
FCF(TTM)0.19
FCFY2.28%
OCF(TTM)0.2
OCFY2.42%
SpS1.56
BVpS4.15
TBVpS0.78
PEG (NY)N/A
PEG (5Y)N/A
Graham Number2.37
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.76% | ||
| ROE | 1.08% | ||
| ROCE | 4.19% | ||
| ROIC | 2.86% | ||
| ROICexc | 4.95% | ||
| ROICexgc | N/A | ||
| OM | 12.47% | ||
| PM (TTM) | 2.88% | ||
| GM | 80.92% | ||
| FCFM | 12.41% |
ROA(3y)2.14%
ROA(5y)0.07%
ROE(3y)3.08%
ROE(5y)0.28%
ROIC(3y)3.96%
ROIC(5y)N/A
ROICexc(3y)5.88%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)5.82%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y132.1%
ROICexc growth 5YN/A
OM growth 3Y125.53%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.9%
GM growth 5Y2.08%
F-Score3
Asset Turnover0.27
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.13 | ||
| Debt/EBITDA | 0.05 | ||
| Cap/Depr | 7.67% | ||
| Cap/Sales | 0.75% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 59.17% | ||
| Profit Quality | 430.43% | ||
| Current Ratio | 1.94 | ||
| Quick Ratio | 1.94 | ||
| Altman-Z | 3.6 |
F-Score3
WACC8.66%
ROIC/WACC0.33
Cap/Depr(3y)9.42%
Cap/Depr(5y)8.61%
Cap/Sales(3y)0.86%
Cap/Sales(5y)0.89%
Profit Quality(3y)466.06%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-14.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-133.33%
EPS Next Y-6.21%
EPS Next 2Y86.09%
EPS Next 3Y70.74%
EPS Next 5YN/A
Revenue 1Y (TTM)59.34%
Revenue growth 3Y40.63%
Revenue growth 5Y46.32%
Sales Q2Q%94.1%
Revenue Next Year60.05%
Revenue Next 2Y38.57%
Revenue Next 3Y27.33%
Revenue Next 5YN/A
EBIT growth 1Y46.83%
EBIT growth 3Y217.15%
EBIT growth 5YN/A
EBIT Next Year76.68%
EBIT Next 3Y40.05%
EBIT Next 5YN/A
FCF growth 1Y-12.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-10.32%
OCF growth 3YN/A
OCF growth 5YN/A
VITALHUB CORP / VHI.CA FAQ
What is the fundamental rating for VHI stock?
ChartMill assigns a fundamental rating of 6 / 10 to VHI.CA.
What is the valuation status of VITALHUB CORP (VHI.CA) stock?
ChartMill assigns a valuation rating of 5 / 10 to VITALHUB CORP (VHI.CA). This can be considered as Fairly Valued.
Can you provide the profitability details for VITALHUB CORP?
VITALHUB CORP (VHI.CA) has a profitability rating of 7 / 10.
Can you provide the financial health for VHI stock?
The financial health rating of VITALHUB CORP (VHI.CA) is 7 / 10.